Cabotegravir / Rilpivirine IM

U.S. Brand Name
Cabenuva
Abbreviation(s)
CAB/RPV IM
First U.S. Approval
Component ARVs
Cabotegravir
Rilpivirine (IM)
NRTI Based?
No
One Dose Daily?
No
Single Tablet Regimen
No
U.S. FDA Label
Cabenuva Label
U.S. Manufacturer
ViiV Healthcare
Other Reference Links
Clinical Info HIV Drug Database
National HIV Curriculum
Adult dosing
Pediatric dosing
References
Assistance Programs
ViiV Connect
Displaying 1 - 1 of 1
Interaction Color Code Clinical Bottom Line Clinical Effects Drug 1 effect Drug 2 dose Drug 2 effect Management
Rilpivirine
Subscribe to Cabotegravir / Rilpivirine IM